Diabetes Mellitus: all 11,089 studies
Page 109 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes CareCompletedNCT00194558Not applicable
- Sleep Apnea in Look AHEAD (Action for Health in Diabetes)Status unknownNCT00194259
- Local Registration Trial in China Humalog Mix 50CompletedNCT00191581Phase 3
- Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 DiabetesCompletedNCT00191464Phase 4
- Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 DiabetesCompletedNCT00191178Phase 4
- Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 DiabetesStatus unknownNCT00190502Not applicable
- Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic PatientsCompletedNCT00189774Phase 2/3
- Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes MellitusCompletedNCT00187564Not applicable
- Internet Diabetes Self-Management WorkshopCompletedNCT00185601Not applicable
- Olmesartan Medoxomil in Diabetes MellitusCompletedNCT00185159Phase 3
- Ischemic Injury and Ischemic Preconditioning in DiabetesCompletedNCT00184821
- Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCompletedNCT00184665Phase 3
- Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesCompletedNCT00184639Phase 3
- Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.CompletedNCT00184626Phase 4
- Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 DiabetesCompletedNCT00184613Phase 1
- Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesCompletedNCT00184574Phase 3
- Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 DiabetesCompletedNCT00184561Phase 4
- Diabetes Prevention Program in Schizophrenia [DPPS]Status unknownNCT00182494Phase 4
- Evaluation of Continuity of Care at a Health Service OrganizationCompletedNCT00182286
- Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose ElevationStatus unknownNCT00182026Not applicable
- Improving Diabetes Outcomes With Activity, Nutrition and MedicationCompletedNCT00179374Not applicable
- Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney TransplantationTerminatedNCT00177138Phase 4
- Trial Comparing Care in Multiple Clinics Versus Care in a Cardiac, Diabetes and Kidney Care ClinicCompletedNCT00175721Not applicable
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCompletedNCT00174993Phase 3
- Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsCompletedNCT00174824Phase 4
- Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 DiabetesCompletedNCT00174681Phase 4
- Insulin Glulisine in Diabetes Mellitus, Type 2CompletedNCT00174668Phase 3
- Opposing Step-by-step Insulin Reinforcement to Intensified StrategyCompletedNCT00174642Phase 3
- The Role of Regulatory T Cell in Patients With Type 1 Diabetes MellitusStatus unknownNCT00173641
- Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in TaiwanStatus unknownNCT00172757
- Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplantCompletedNCT00171717Phase 4
- Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsCompletedNCT00171496Phase 4
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+BenazeprilTerminatedNCT00171119Phase 4
- Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 DiabetesCompletedNCT00168519Not applicable
- Patient Provider Partnership: Improving Diabetes Care in the CommunityCompletedNCT00167284Not applicable
- Metabolic Effects of AlcoholCompletedNCT00167115Not applicable
- The Impact of Rosiglitazone on Regression of AtherosclerosisSuspendedNCT00166803Not applicable
- Pilot Study of the Navigator Continuous Glucose MonitorCompletedNCT00166673Phase 2/3
- A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.CompletedNCT00162344Phase 4
- PPAR - Combination With MetforminCompletedNCT00162240Phase 3
- PPAR-COMBO With SulfonylureaCompletedNCT00162175Phase 3
- Microvascular Response in Diabetes MellitusStatus unknownNCT00160927
- Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational DiabetesWithdrawnNCT00160485Phase 4
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable
- Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough CollaborativeCompletedNCT00160017
- MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)CompletedNCT00157729Phase 2
- Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)CompletedNCT00157586Phase 3
- Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early NephropathyTerminatedNCT00157508Phase 2
- Ezetimibe and Simvastatin in Dyslipidemia of DiabetesCompletedNCT00157482Phase 2
- Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDCompletedNCT00157339Phase 3
- Efficacy and Safety of ATL-962 in Obese DiabeticsCompletedNCT00156897Phase 2
- Studies of Organ Transplantation in Animals and ManCompletedNCT00156364
- The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic PatientsStatus unknownNCT00155922
- The Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes WomenTerminatedNCT00155610
- Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.Status unknownNCT00155142
- Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 DiabetesCompletedNCT00154414Phase 2
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00154401Phase 2
- WelChol® and Insulin in Treating Patients With Type 2 DiabetesCompletedNCT00151749Phase 3
- LANN-study: Lantus, Amaryl, Novorapid, Novomix StudyCompletedNCT00151697Phase 3
- Community Diabetes Education Program Evaluation "Code Evaluation"CompletedNCT00151190Phase 3
- Stepping Up to Health: Feedback to Promote Physical Activity in DiabetesCompletedNCT00151021Not applicable
- Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseCompletedNCT00150410Phase 3
- Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)CompletedNCT00148538Phase 3
- Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic PatientsCompletedNCT00147836Not applicable
- The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I DiabetesCompletedNCT00147342
- A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 DiabetesCompletedNCT00146484Phase 2
- Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 DiabetesCompletedNCT00145925Phase 3
- The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes MellitusCompletedNCT00145379Phase 4
- Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin DoseStatus unknownNCT00145353Phase 4
- Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes MellitusCompletedNCT00145093Phase 3
- A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 DiabetesStatus unknownNCT00144144Phase 4
- Placebo and Active Controlled Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00143520Phase 2/3
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143338Phase 2
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143104Phase 2
- Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 DiabetesStatus unknownNCT00143013
- Breaking Down Barriers to Diabetes Self-CareCompletedNCT00142922Not applicable
- Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 DiabetesCompletedNCT00141986Phase 1
- Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesCompletedNCT00141492Phase 2
- Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 DiabetesCompletedNCT00141232Phase 4
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138619Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00138606Phase 3
- Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%CompletedNCT00138593Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00138580Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138567Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00138554Phase 3
- Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00138541Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00138515Phase 3
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00136773Phase 4
- Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)CompletedNCT00135941Phase 3
- Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal InsulinCompletedNCT00135096Phase 3
- Variable Bolus Regimen 1-2-3 for Type 2 Diabetes MellitusCompletedNCT00135083Phase 3
- Hospital In-Patient Insulin StudyTerminatedNCT00135070Phase 4
- Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinCompletedNCT00135057Phase 3
- Erectile Dysfunction and Diabetes MellitusCompletedNCT00134329
- A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlCompletedNCT00134147Phase 3
- A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic ControlCompletedNCT00133718Phase 4
- MY PALS: A Community-Based Physical Activity Support Program for Older AdultsCompletedNCT00132288Not applicable
- Efficacy of Diazoxide in Type 1 DiabetesCompletedNCT00131755Phase 4
- The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)CompletedNCT00131287Phase 3
- An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)TerminatedNCT00130806Phase 3